Andrew Haupt Bio

Andrew Haupt represents emerging to multinational life sciences companies in all aspects of their legal affairs, including complex license, collaboration and other partnering agreements, mergers and acquisitions, venture capital financings, and other financial and commercial transactions. His clients include pharmaceutical, biotech, vaccine, medical device, technology, and emerging growth companies as well as private equity firms. Prior to private practice, Andrew was corporate counsel to a publicly traded biopharmaceutical company.